Simplex Trading’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19K Buy
+86
New +$1.37K ﹤0.01% 8544
2025
Q2
Sell
-963
Closed -$8.75K 8499
2025
Q1
$7K Buy
963
+882
+1,089% +$6.78K ﹤0.01% 7283
2024
Q4
$0 Sell
81
-2,821
-97% -$15.6K ﹤0.01% 8379
2024
Q3
$14K Sell
2,902
-20,391
-88% -$88.8K ﹤0.01% 6931
2024
Q2
$84K Sell
23,293
-4,873
-17% -$15.5K ﹤0.01% 5540
2024
Q1
$90K Buy
28,166
+25,599
+997% +$99K ﹤0.01% 5690
2023
Q4
$12K Buy
+2,567
New +$11.7K ﹤0.01% 7276
2023
Q3
Sell
-10,075
Closed -$66.6K 8535
2023
Q2
$67K Buy
10,075
+6,597
+190% +$49.1K ﹤0.01% 5519
2023
Q1
$30K Buy
3,478
+1,525
+78% +$13.4K ﹤0.01% 6479
2022
Q4
$14K Buy
1,953
+866
+80% +$6.74K ﹤0.01% 7195
2022
Q3
$7K Buy
+1,087
New +$10.2K ﹤0.01% 8485
2022
Q2
Sell
-4,135
Closed -$36.4K 9825
2022
Q1
$57K Buy
4,135
+3,232
+358% +$50.8K ﹤0.01% 6952
2021
Q4
$25K Buy
903
+210
+30% +$6.44K ﹤0.01% 8104
2021
Q3
$27K Buy
693
+400
+137% +$14.5K ﹤0.01% 8151
2021
Q2
$11K Sell
293
-8,766
-97% -$341K ﹤0.01% 9016
2021
Q1
$364K Buy
+9,059
New +$490K ﹤0.01% 3866
2020
Q1
Sell
-783
Closed -$21.8K 7503
2019
Q4
$23K Buy
+783
New +$22.5K ﹤0.01% 5831

Other funds holding ADPT

Simplex Trading's ADPT Position: Q1 2026 in Review

Simplex Trading opened a new position in Adaptive Biotechnologies (ADPT) in Q1 2026: 86 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #8544 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ADPT as recently as Q1 2025.

Simplex Trading first reported a position in ADPT in Q4 2019 and has held it in 17 quarters since. The position peaked at $364K in Q1 2021. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Simplex Trading held 86 shares of Adaptive Biotechnologies worth $1.19K as of Q1 2026.
  • Adaptive Biotechnologies was a new Simplex Trading position in Q1 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8544 holding.
  • Simplex Trading first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 17 quarters since.
  • Simplex Trading's Adaptive Biotechnologies position peaked at $364K in Q1 2021.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.